Toxoplasmosis in Cats: Zoonotic Risk, Clinical Signs, and Public Health Implications

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-06-06

Key Takeaways

• Cats are definitive hosts for Toxoplasma gondii, shedding environmentally resistant oocysts in feces for 1-3 weeks post-infection, making them the primary source of environmental contamination for intermediate hosts, including humans.
• Clinical toxoplasmosis in cats is most prevalent in immunocompromised individuals or kittens, manifesting as respiratory distress (interstitial pneumonia), ocular disease (uveitis, chorioretinitis), or neurological signs (ataxia, seizures) due to tachyzoite replication in tissues.
• Diagnosis relies on a combination of serological antibody detection (ELISA, immunofluorescence) and molecular methods like PCR for parasite DNA in biological samples, with histopathology confirming tissue invasion.
• Human infection primarily occurs through ingestion of undercooked meat containing tissue cysts or via oocysts from contaminated soil/water/produce, with cat ownership being a manageable risk factor through proper litter box hygiene and indoor housing.
• Treatment for feline toxoplasmosis typically involves clindamycin or trimethoprim-sulfonamide combinations to target tachyzoites, though tissue cysts are not eliminated, and adjunctive corticosteroids may be used cautiously for inflammatory conditions.
• Public health control necessitates a One Health approach, focusing on reducing free-roaming cat populations, promoting responsible litter box management, educating the public on dietary risks, and developing effective feline vaccines to minimize environmental oocyst shedding.

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. Felids, particularly domestic cats (Felis catus), serve as the definitive hosts in which the sexual phase of the parasite life cycle occurs, leading to fecal shedding of environmentally resistant oocysts [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>]. This role positions cats as the primary source of infection for intermediate hosts, including humans and many warm-blooded animals [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. The present article provides a detailed veterinary-focused examination of T. gondii infection in cats, emphasizing the biological mechanisms underlying transmission, clinical presentation in feline patients, diagnostic strategies, and the broader public health implications of feline toxoplasmosis. The discussion integrates recent molecular, serological, and epidemiological findings to support evidence-based veterinary practice.

Etiology and Life Cycle

Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing forms), bradyzoites (slowly dividing, cyst-forming stages in tissues), and sporozoites (within sporulated oocysts) [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. Cats become infected predominantly through ingestion of tissue cysts containing bradyzoites from infected intermediate hosts (e.g., rodents, birds) or, less efficiently, through ingestion of sporulated oocysts from contaminated environments [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>]. Following ingestion, bradyzoites are released in the feline small intestine, where they invade enterocytes and undergo multiple rounds of asexual replication (endodyogeny) followed by sexual development (gametogony) [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>]. The sexual phase culminates in the formation of unsporulated oocysts that are shed in feces, typically beginning 3 to 10 days post-infection and continuing for 1 to 3 weeks [<a href="#ref-12">12</a>, <a href="#ref-13">13</a>]. A single cat can excrete millions of oocysts during this period [<a href="#ref-11">11</a>]. Oocysts sporulate (become infectious) within 1 to 5 days in the environment under adequate temperature and humidity [<a href="#ref-3">3</a>, <a href="#ref-14">14</a>].

Extraintestinal dissemination occurs when tachyzoites penetrate the intestinal wall and disseminate via the lymphatics and bloodstream to various tissues, including skeletal muscle, myocardium, retina, and central nervous system (CNS) [<a href="#ref-11">11</a>, <a href="#ref-15">15</a>]. Immune pressure drives tachyzoite-to-bradyzoite conversion, resulting in the formation of latent tissue cysts that persist for the life of the host [<a href="#ref-8">8</a>]. The molecular regulation of this stage conversion involves dynamic changes in microRNA expression within the feline small intestine, as demonstrated by transcriptomic profiling during acute infection [<a href="#ref-15">15</a>]. The pre-sexual stages have been characterized at the single-cell level, revealing distinct proliferative mechanisms that are essential for gametocyte formation [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>].

Epidemiology

Seroprevalence of T. gondii in domestic cat populations varies widely depending on geographic location, management practices (indoor versus outdoor access), age, and prey availability [<a href="#ref-12">12</a>, <a href="#ref-16">16</a>]. A serosurvey in Hong Kong reported seroprevalences of 18.9% in privately-owned cats and 37.2% in community cats, with outdoor access and raw meat consumption identified as significant risk factors [<a href="#ref-12">12</a>]. In Jordan, seroprevalence among cats reached 41.3%, with stray cats showing higher rates than household cats [<a href="#ref-16">16</a>]. Stray cat populations in Bangkok, Thailand, exhibited a 12.3% molecular detection rate in fecal samples using PCR, highlighting the potential for environmental contamination [<a href="#ref-13">13</a>]. In Brazil, high seroprevalence has been documented in dogs (52.77%) in the Pantanal region and in cats from urban informal settlements where environmental degradation and social marginalization correlate with increased human exposure [<a href="#ref-1">1</a>, <a href="#ref-17">17</a>].

The phrase "toxoplasmosis cat lady disease" has entered popular discourse, often conflating cat ownership with toxoplasmosis risk in a stigmatizing manner [<a href="#ref-6">6</a>, <a href="#ref-18">18</a>]. Epidemiological evidence, however, demonstrates that the primary risk factors for human infection are ingestion of undercooked meat, consumption of contaminated water or vegetables, and poor hand hygiene following gardening or litter box cleaning, rather than cat ownership per se [<a href="#ref-5">5</a>, <a href="#ref-7">7</a>]. Nevertheless, cats remain the essential source of environmental oocysts, and communities with high densities of free-roaming or stray cats exhibit elevated environmental contamination levels [<a href="#ref-1">1</a>, <a href="#ref-13">13</a>]. Seroprevalence studies in veterinary professionals reveal a 42% positivity rate in Mexico, reflecting occupational exposure [<a href="#ref-6">6</a>]. Knowledge and practices regarding toxoplasmosis among pregnant women and university students remain suboptimal in many regions, emphasizing the need for targeted educational interventions [<a href="#ref-7">7</a>, <a href="#ref-19">19</a>].

The table below summarizes selected feline seroprevalence studies from the recent literature.

Clinical Signs in Cats

The majority of immunocompetent cats infected with T. gondii remain subclinical or exhibit mild, self-limiting signs such as transient fever, lethargy, and anorexia during the acute phase [<a href="#ref-20">20</a>, <a href="#ref-21">21</a>]. Clinical disease occurs most frequently in kittens, immunosuppressed cats (e.g., feline leukemia virus or feline immunodeficiency virus co-infected individuals), or those receiving immunosuppressive therapy [<a href="#ref-22">22</a>, <a href="#ref-23">23</a>]. The predominant clinical manifestations involve the respiratory, ocular, and central nervous systems [<a href="#ref-21">21</a>, <a href="#ref-24">24</a>].

Respiratory toxoplasmosis presents as dyspnea, tachypnea, and cough due to interstitial pneumonia caused by tachyzoite replication in alveolar macrophages and pneumocytes [<a href="#ref-20">20</a>, <a href="#ref-21">21</a>]. Ocular disease typically manifests as anterior uveitis, chorioretinitis, and panophthalmitis; these lesions may be unilateral or bilateral and can lead to glaucoma or retinal detachment [<a href="#ref-24">24</a>]. Neurological signs include ataxia, circling, head pressing, seizures, and behavioral changes; these arise from focal or diffuse encephalitis, often in the cerebrum or brainstem [<a href="#ref-20">20</a>, <a href="#ref-25">25</a>]. Pyogranulomatous and neutrophilic lymphadenitis has been described in a population of cats presenting to a referral hospital, with nine cases exhibiting steroid-responsive lymphadenitis, suggesting an immune-mediated component [<a href="#ref-23">23</a>]. Additionally, reproductive tract infection can cause abortion or stillbirth in pregnant queens, as confirmed by histopathological and molecular detection of T. gondii in reproductive tissues [<a href="#ref-21">21</a>, <a href="#ref-26">26</a>].

Chronic sequelae are rare in cats but can include recrudescent ocular inflammation and persistent neurological deficits [<a href="#ref-22">22</a>]. The severity of clinical signs correlates with the parasite burden and the host's Th1-type immune response, which involves interferon-gamma and tumor necrosis factor-alpha [<a href="#ref-8">8</a>, <a href="#ref-15">15</a>].

Pathology

Gross pathological findings in acute fatal toxoplasmosis include multifocal necrotic lesions in the liver, spleen, pancreas, lungs, and lymph nodes [<a href="#ref-23">23</a>, <a href="#ref-26">26</a>]. Histologically, these lesions are characterized by necrosis, mononuclear cell infiltration, and the presence of free or intracellular tachyzoites within macrophages, endothelial cells, and parenchymal cells [<a href="#ref-20">20</a>, <a href="#ref-26">26</a>]. In the CNS, glial nodules, perivascular cuffing, and necrotic foci containing cysts are observed [<a href="#ref-20">20</a>, <a href="#ref-25">25</a>]. Ocular pathology reveals infiltration of inflammatory cells into the uvea, retina, and vitreous humor, often accompanied by cyst formation within the retinal pigment epithelium [<a href="#ref-24">24</a>]. The chronic stage is defined by the presence of thin-walled tissue cysts containing hundreds of bradyzoites, predominantly in skeletal muscle, myocardium, and brain, without associated inflammation [<a href="#ref-15">15</a>, <a href="#ref-22">22</a>].

Diagnostics

A definitive diagnosis of feline toxoplasmosis requires a combination of serological, molecular, and histopathological approaches [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>, <a href="#ref-27">27</a>]. Serological detection of anti-T. gondii antibodies (IgG and IgM) is the most commonly employed screening method [<a href="#ref-6">6</a>, <a href="#ref-12">12</a>]. Commercial enzyme-linked immunosorbent assays (ELISAs) and indirect immunofluorescence assays are widely available [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>]. The double-antigen sandwich colloidal gold immunochromatographic strip demonstrated high sensitivity and specificity for detection of antibodies across multiple host species, including cats, and can be used for rapid field screening [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>]. A SAG1-based colloidal gold strip has also been validated for swine, and its principle is transferable to feline serodiagnosis [<a href="#ref-9">9</a>].

Molecular detection via polymerase chain reaction (PCR) targeting the B1 gene or the 529-bp repetitive element is the gold standard for confirming active infection and for detecting parasite DNA in feces, aqueous humor, cerebrospinal fluid, or tissue biopsies [<a href="#ref-13">13</a>, <a href="#ref-27">27</a>]. An antisense PCR assay has recently been developed and evaluated for detection of T. gondii in domestic cats, offering improved sensitivity by targeting the ribosomal RNA transcript rather than genomic DNA [<a href="#ref-27">27</a>]. Fecal PCR is particularly useful for identifying oocyst-shedding cats, although shedding is intermittent and short-lived compared to the chronic carrier state [<a href="#ref-11">11</a>, <a href="#ref-13">13</a>]. Histopathological examination of biopsy or necropsy specimens, coupled with immunohistochemistry, remains the most direct method for demonstrating tachyzoites or cysts in tissue sections [<a href="#ref-23">23</a>, <a href="#ref-26">26</a>].

The MIC17A antigen has been proposed as a marker for both entero-epithelial and chronic stage infection, and its detection could improve the sensitivity of serological assays for latent feline toxoplasmosis [<a href="#ref-22">22</a>].

The Mermaid diagram below outlines a recommended diagnostic workflow for a cat with suspected toxoplasmosis.

flowchart TD
 A["Feline patient with clinical signs suggestive of toxoplasmosis"] --> B{"Serological screening"}
 B -->|"IgG-/IgM-"| C["Unlikely active toxoplasmosis; consider other differentials"]
 B -->|"IgG+/IgM+ or IgM+"| D["Probable active or recent infection"]
 D --> E["Molecular confirmation: PCR on blood, CSF, aqueous humor, or feces"]
 E --> F{"PCR result"}
 F -->|"Positive"| G["Confirmed toxoplasmosis; institute treatment"]
 F -->|"Negative"| H["Consider alternative diagnoses or low parasite burden"]
 B -->|"IgG+/IgM-"| I["Chronic/latent infection; evaluate clinical correlation"]
 I --> J{"Signs compatible?"}
 J -->|"Yes"| K["Consider serology titer rise or PCR on affected tissue"]
 J -->|"No"| L["Toxoplasmosis unlikely cause of current illness"]
 G --> M["Monitor response to therapy; repeat serology/PCR as needed"]

Treatment and Control

The primary therapeutic agents used in feline toxoplasmosis are clindamycin (administered orally or parenterally at 10-12 mg/kg every 12 hours for 2-4 weeks) and trimethoprim-sulfonamide combinations [<a href="#ref-20">20</a>, <a href="#ref-21">21</a>]. Clindamycin is effective against tachyzoites but does not eliminate tissue cysts [<a href="#ref-8">8</a>]. Adjunctive therapy with corticosteroids may be necessary to control ocular inflammation or immune-mediated damage, but this must be used cautiously to avoid exacerbating infection [<a href="#ref-24">24</a>]. For abortive or reproductive tract infections, early intervention with clindamycin can reduce fetal loss [<a href="#ref-21">21</a>].

Control strategies focus on preventing oocyst shedding and environmental contamination. Indoor housing reduces exposure to infected prey, and feeding commercial cooked or processed diets eliminates the primary route of infection for cats [<a href="#ref-12">12</a>, <a href="#ref-16">16</a>]. Regular removal of feces from litter boxes (within 24 hours, before sporulation occurs) and proper disposal of cat feces minimize environmental contamination [<a href="#ref-18">18</a>]. Freezing cat litter to -20 degrees Celsius for 24 hours can inactivate oocysts, but this is often impractical for owners [<a href="#ref-14">14</a>].

Vaccine development remains an active research area. Gene-edited live-attenuated vaccines have been generated by deleting essential virulence genes (e.g., Δgra17, Δcdpk2), and they have shown promise in inducing protective immunity against acute and chronic infection in murine models [<a href="#ref-3">3</a>]. An mRNA vaccine strategy, incorporating multiple T. gondii antigens (including GRA6, ROP18, and SAG1), has been proposed within a One Health framework [<a href="#ref-8">8</a>]. However, no licensed vaccine for cats is currently commercially available.

Public Health Implications

The zoonotic risk posed by T. gondii is primarily associated with the ingestion of oocysts from contaminated soil, water, or produce, and the consumption of undercooked meat containing tissue cysts [<a href="#ref-5">5</a>, <a href="#ref-28">28</a>, <a href="#ref-29">29</a>]. Cats are the only definitive hosts that shed oocysts, making them a critical point of intervention for public health programs [<a href="#ref-1">1</a>, <a href="#ref-18">18</a>]. The "toxoplasmosis cat lady disease" stereotype, which erroneously attributes toxoplasmosis risk solely to cat ownership, has been critiqued as scientifically unfounded and potentially harmful, as it may discourage responsible pet ownership while diverting attention from proven risk factors such as dietary habits and occupational exposure [<a href="#ref-6">6</a>, <a href="#ref-18">18</a>, <a href="#ref-30">30</a>].

Immunocompromised individuals (e.g., organ transplant recipients, patients with HIV/AIDS, or those on immunosuppressive drugs) are at increased risk for severe or reactivated toxoplasmosis, including cerebral toxoplasmosis and disseminated disease [<a href="#ref-20">20</a>, <a href="#ref-25">25</a>]. Pregnant women who acquire primary infection during gestation risk transplacental transmission to the fetus, which can result in chorioretinitis, intracranial calcifications, hydrocephalus, or fetal death [<a href="#ref-5">5</a>, <a href="#ref-7">7</a>]. The association between T. gondii seropositivity and psychiatric disorders, such as schizophrenia and psychotic experiences, has been investigated in cohort studies, with some evidence linking childhood infection to reduced grey matter volume in specific brain regions [<a href="#ref-25">25</a>]. Ocular toxoplasmosis, a common cause of posterior uveitis in many populations, can occur both congenitally and postnatally [<a href="#ref-24">24</a>, <a href="#ref-30">30</a>].

Seroprevalence in livestock (cattle, sheep, goats, pigs) and wildlife (deer, equids) across multiple countries indicates widespread environmental contamination and highlights the role of meat as a transmission vehicle [<a href="#ref-4">4</a>, <a href="#ref-14">14</a>, <a href="#ref-26">26</a>, <a href="#ref-28">28</a>, <a href="#ref-31">31</a>, <a href="#ref-32">32</a>, <a href="#ref-33">33</a>]. Respiratory and ocular disease in dogs and cats from the same environments further suggests that companion animals can serve as sentinels for human risk [<a href="#ref-12">12</a>, <a href="#ref-17">17</a>]. Enhanced surveillance combining serological, molecular, and spatial epidemiology is essential to quantify the contribution of feline oocyst shedding to human disease burden [<a href="#ref-1">1</a>, <a href="#ref-13">13</a>, <a href="#ref-16">16</a>].

One Health Perspectives

The control of toxoplasmosis requires a One Health approach that integrates veterinary, medical, and environmental expertise [<a href="#ref-1">1</a>, <a href="#ref-8">8</a>]. Strategies include reducing free-roaming cat populations through trap-neuter-return programs, promoting responsible litter box hygiene, enforcing meat inspection and cooking guidelines, and educating the public about transmission routes [<a href="#ref-1">1</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>]. Advances in point-of-care diagnostics (e.g., immunochromatographic strips) facilitate rapid screening of cats in high-prevalence regions and support informed management decisions [<a href="#ref-2">2</a>, <a href="#ref-9">9</a>]. The development of an effective vaccine for cats would dramatically reduce oocyst shedding and environmental contamination, providing a powerful tool for public health protection [<a href="#ref-3">3</a>, <a href="#ref-8">8</a>].

Conclusion

Toxoplasmosis in cats is a complex parasitic disease with significant implications for feline health and for human zoonotic risk. The clinical spectrum ranges from subclinical infection to life-threatening systemic disease, particularly in young or immunocompromised animals. Accurate diagnosis relies on serological and molecular methods, with novel assays improving detection sensitivity and convenience. Epidemiological studies underscore the importance of environmental contamination by feline oocysts as the primary source of human infection, yet the risk from cat ownership is manageable through simple preventive measures. Efforts to develop effective vaccines and to integrate control strategies across species and sectors remain critical priorities. Veterinary practitioners play a pivotal role in advising clients, diagnosing infection, and contributing to public health surveillance for this globally important zoonosis.

Related Clinical & Scientific Guides

• Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention
• Toxoplasmosis in Cats and the Risk of Brain Infection in Humans
• Dog Heartworm and Tick-Borne Disease Prevention

References